www.veracyte.com Open in urlscan Pro
141.193.213.21  Public Scan

URL: https://www.veracyte.com/
Submission: On September 18 via manual from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

 * Tests
   * Diseases areas
      * Cancer
      * Thyroid cancer
      * Prostate cancer
      * Lung cancer
      * Breast cancer
      * Bladder cancer
     
      * Other
      * Interstitial lung disease
     
     Portfolio and test expansion
   * Products
      * Thyroid Cancer Afirma Genomic Sequencing Classifier
      * Prostate Cancer Decipher Prostate Genomic Classifier
      * Breast Cancer Prosigna Breast Cancer Assay
     
      * Interstitial Lung Disease Envisia Genomic Classifier
      * Bladder Cancer Decipher Bladder Genomic Classifier
     
      * Instructions for use
      * Quality certificates
      * Safety data sheets
     
     Enabling global access
   * Pipeline
      * Portfolio and test expansion
      * Enabling global access
      * MRD technology
   
   * Publications
   
 * Partner Services
   * Biopharma services
   * IVD services
   
 * Company
   * About us
      * Who we are
      * Leadership
      * Corporate recognition
     
     Culture
   * Contact
   
 * News & Events
   * News
      * Press releases
      * In the news
     
     Who we are
   * Events
   
 * Careers
   * Culture
   * Job openings
   
 * Investors
   * Overview
   * Press Releases
   * Events & Presentations
   * Financials
      * SEC filings
      * Quarterly results
      * Annual reports
      * Stock information
      * Analyst coverage
     
     ESG information
   * Governance
      * Governance overview
      * Board of directors
      * Committee Composition
      * Leadership
      * ESG information
     
     Annual reports
   * Investor Resources
      * Investor FAQs
      * Information request
      * Email alerts
     
     Annual reports
   

AT VERACYTE WE BELIEVE


EXCEPTIONAL CANCER CARE BEGINS WITH EXCEPTIONAL DIAGNOSTICS.

Who we are


NEWS UPDATE

C2i Genomics is now a part of Veracyte

Press release


VERACYTE’S MOLECULAR TESTS EMPOWER CLINICIANS WITH THE HIGH-VALUE INSIGHTS THEY
NEED IN THE RACE TO DIAGNOSE AND TREAT CANCER.

THYROID CANCER

Afirma® Genomic Sequencing Classifier



PROSTATE CANCER

Decipher® Prostate Genomic Classifier



BREAST CANCER

Prosigna® Breast Cancer Assay



ILD

Envisia® Genomic Classifier



Bladder Cancer

Decipher® Bladder Genomic Classifier




PROVIDING HIGH-VALUE INSIGHTS


CLINICIANS AND PATIENTS MAY STRUGGLE WITH UNCERTAINTY DURING CANCER DIAGNOSIS
AND TREATMENT DECISION-MAKING. OUR TESTS CAN HELP THEM MOVE FORWARD WITH
CONFIDENCE.

Portfolio and test expansion


TESTS THAT HELP CLINICIANS GUIDE AND ASSURE PATIENTS AT PIVOTAL MOMENTS

There are pivotal moments in a patient’s cancer care journey where key decisions
can impact the patient’s pathway and outcome. Whether diagnosing suspicious
symptoms or determining treatment next steps, deciding on the best path forward
can be a challenging and uncertain endeavor without the right data. Veracyte’s
tests provide answers that enable clinicians and their patients to make more
informed and confident decisions. Our diagnostic and prognostic tests provide
clarity for some of the most complex diseases, helping patients avoid
unnecessary procedures and speeding time to appropriate diagnosis and treatment.

ELEVATING THE STANDARD OF CARE FOR TOMORROW

Understanding cancer at the molecular level enables more personalized approaches
to diagnosis and treatment. Veracyte’s tests deliver actionable insights rooted
in both the known and the novel.

OUR proven framework


VERACYTE’S APPROACH TO DIAGNOSTICS

We collaborate closely with clinicians and scientists to identify unmet needs
that stand in the way of better care. And then, we find the answers. Our
rigorous process enables more confident decision-making for clinicians, giving
patients access to a higher standard of care.


WE SEEK TO MAKE LEADING DIAGNOSTICS ACCESSIBLE TO PATIENTS ALL OVER THE WORLD.

400K

The number of patients our tests have benefited.1

>7M

The number of people globally each year who are diagnosed with a cancer that our
tests address.2-4

1


IDENTIFY CLINICAL UNMET NEEDS

We work with clinicians and scientists to develop our tests. Through a rigorous
multi-disciplinary innovation process we identify unmet needs and create
solutions that make clinicians’ and patients’ lives easier.

2


DEVELOP HIGH-PERFORMANCE TESTS

We take a rigorous approach to ensuring product performance and utility,
building evidence across a broad range of studies. Clinicians and patients need
high-quality, reliable results they can trust.

3


RAMP PATIENT TESTING GLOBALLY

We make our leading diagnostics widely available through a flexible CLIA- and in
vitro diagnostic (IVD)-based model. We supplement this with our proven ability
to build clinical evidence that drives reimbursement, encourages clinician
adoption, and prompts guideline inclusion for our tests.


ESG REPORT

Veracyte’s Environmental, Social and Governance (ESG) Report sets the foundation
for our ESG performance and articulates our ambitions to build a more
sustainable, equitable future.

ESG Report


MAKING OUR TESTS AVAILABLE WORLDWIDE



Through our centralized CLIA lab-based approach in the US and our growing menu
of distributed IVDs to serve global markets, we aim to transform cancer care for
patients all over the world.



Enabling global access


JOIN OUR TEAM

Veracyte offers fulfilling career opportunities for curious, driven, and
patient-oriented people who are inspired to find answers to some of the most
challenging questions in medicine. Join us.

Working at Veracyte


REFERENCES

 1. Company data on file.

 2. Cancer. World Health Organization. Published February 3, 2022. Accessed July
    19, 2023. https://www.who.int/news-room/fact-sheets/detail/cancer

 3. Thyroid Cancer – Statistics. Cancer.Net. Accessed July 19, 2023.
    https://www.cancer.net/cancer-types/thyroid-cancer/statistics

 4. Bladder Cancer. International Agency for Research on Cancer. Accessed July
    19, 2023. https://www.iarc.who.int/cancer-type/bladder-cancer/

© 2024 Veracyte, Inc. All rights reserved.

OFFICES

 * SOUTH SAN FRANCISCO, CA
   
   6000 Shoreline Court, Suite 300
   
   
   South San Francisco, CA  94080 
   
   United States

 * MARSEILLE, FRANCE
   
   163 Avenue de Luminy
   
   
   Marseille  13009 
   
   FRANCE

 * SAN DIEGO, CA
   
   6925 Lusk Boulevard, Suite 200
   
   
   San Diego, CA  92121 
   
   United States

 * AUSTIN, TX
   
   12357-A Riata Trace Parkway
   Building 5, Suite 100
   
   Austin, TX  78727 
   
   United States

 * HAIFA, ISRAEL
   
   Nahum Het 7
   
   
   Haifa, Israel  3508506 
   
   ISRAEL

HELPFUL LINKS

 * Privacy information center
 * Terms of Use
 * Terms of Sale
 * No Surprises Act
 * Business ethics and compliance
 * Accessibility
 * Cookies Settings

CONNECT

 * Contact
 * LinkedIn
 * X (Twitter)
 * YouTube

This website uses cookies to measure and analyze website performance and usage,
enhance user experiences, personalize content and ads, and provide social media
and other third party features. By clicking "Accept All Cookies", you are
directing Veracyte to disclose information that may be considered personal
information to third parties for these purposes. You may click the "Reject All"
button to reject all cookies except those that are necessary for the website to
function and cannot be switched off in our system. You may also Additional
information about the cookies this website uses is available in our Cookies
Settings.
Cookies Settings Reject All Accept All Cookies



COOKIE PREFERENCE CENTER

When you visit our website, we store cookies on your browser to collect
information which is used to measure and analyze website performance and usage,
enhance user experiences, personalize content and ads, and provide social media
and other third-party features. You can choose to opt out of all third-party
cookies on our website, other than those that are “necessary”, by turning off
the category below; however, this may impact the functionality of the website.
Click on the different category headings to find out more and to change
settings.
More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for our website to function properly and cannot be
switched off in our systems. Without these cookies, we cannot respond to your
requests or provide you with the services you request or access on our website.
For example, we use these cookies to do the following: to remember information
you have entered on forms during a web browser session; for security purposes;
and to route users to specific applications or specific servers. You can set
your browser to block or alert you about these cookies, but if you do so, some
parts of our website will not function properly.

Cookies Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies collect information about how you use our website - e.g. which
pages you visit and if you experience any errors. They allow us to count visits
and traffic sources so we can measure and improve the performance of our
website. For example, they help us to know which pages are the most and least
popular and see how visitors move around the site. Some of our performance
cookies are managed for us by third parties. If you do not allow these cookies
we will not know when you have visited our site and will not be able to monitor
its performance. Where required by law, we will obtain your consent before
placing these cookies.

Cookies Details‎

TARGETING COOKIES

Targeting Cookies

These are third-party cookies that allow us to better reach you with relevant
ads and content—both on our website and on third-party websites, apps and online
services—and to measure and improve our advertising and marketing. These cookies
enable third-party ad companies to track your visits to our website, as well as
other websites, apps and online services, which they use to understand your
interests and activities in order to provide you more relevant ads on behalf of
us and other companies. If you do not allow these cookies, you will still see
ads online. Where required by law, we will obtain your consent before placing
these cookies.

Cookies Details‎
Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices